YCU PR Office, Author at Yokohama City University

2022-06-28

SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is shown to prevent severe illness and death in hemodialysis (HD) patients, but the immune response to vaccines is reduced in this population. This study compared SARS-CoV-2 spike protein antibody titers between HD patients and healthy controls in Japan for up to 6 months following vaccination.

2022-06-21

Volume-Based Radiofrequency Thermocoagulation for Pediatric Insulo-Opercular Epilepsy: A Feasibility Study

BACKGROUND: Stereotactic ablation surgeries including radiofrequency thermocoagulation (RFTC) and laser interstitial thermal therapy are recent less invasive treatment methods for insular epilepsy. Volume-based RFTC after stereoelectroencephalography was first proposed by a French group as a more effective method for seizure relief in insular epilepsy patients than stereoelectroencephalography-guided RFTC.

2022-06-20

The 2nd Online PBL Session with the University of Hawaii John A. Burns School of Medicine

Following the COVID-19 pandemic, the face-to-face meetings are delayed to an unknown date. However, the YCU School of Medicine deems international education essential for our students. As a solution to this issue, the University of Hawaii John A. Burns School of Medicine (JABSOM) kindly offered us an opportunity to hold an online “PBL Hawaii Style Workshop” on March 22nd and 24th, for the second time after the outbreak of COVID-19.

2022-06-14

Chronic Kidney Disease and Clinical Outcomes in Patients with COVID-19 in Japan

Background Identifying predictive factors for coronavirus disease 2019 (COVID-19) is crucial for risk stratification and intervention. Kidney dysfunction contributes to the severity of various infectious diseases. However, the association between on-admission kidney dysfunction and the clinical outcome in COVID-19 patients is unclear.